Metabolic and structural hepatic changes in diabetes and intracerebral haemorrhage: Comparative study of lipid-lowering and antidiabetic drugs
Regulatory Mechanisms in Biosystems · 27.05.2026 · 17 (5) · e26095
DOI: 10.15421/0226095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regulatory Mechanisms in Biosystems, online erschienen am 27.05.2026. Verfasst von O. Dyomshyna und 2 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes is a major global health problem frequently accompanied by hepatic metabolic disturbances. An exper i mental model of streptozotocin-induced type 2 diabetes complicated by intracerebral haemorrhage was established in rats. Pha r macological correction was performed using rosuvastatin, metformin, or vitamin D. Liver morphology was assessed by histolo g ical examination, while lipid and biochemical parameters were evaluated using spectrometric methods. Streptozotocin-induced type 2 diabetes was associated with significant dysregulation of glucose metabolism, hepatic cholesterol and triglyceride levels, and aminotransferase activity. The addition of intracerebral haemorrhage resulted in pronounced macrovesicular steatosis, deter i oration of the hepatic lipid profile, diapedesis haemorrhage, perivascular oedema, and marked lymphocytic infiltration. Rosuvastatin demonstrated the most pronounced corrective effect, leading to near-complete regression of steatosis, normalisation of lipid parameters, prevention of necrotic and haemorrhagic changes, and restoration of lobular liver architecture. Metformin and vitamin D produced moderate improvements in hepatic morphology and lipid metabolism without full normalisation. Intracerebral haemorrhage markedly aggravates hepatic morphofunctional disturbances in streptozotocin-induced type 2 diabetes, promoting the development of macrovesicular steatosis. Among the agents investigated, rosuvastatin exhibited the greatest hepatoprotective potential, whereas metformin and vitamin D showed moderate corrective effects. These findings support diffe r entiated pharmacological approaches and suggest potential benefits of combination therapy in diabetic hepatopathy. From a research perspective, further work should focus on identifying effective combinations of the drugs studied in this experimental model.
Zitieren
APA
Dyomshyna, O., Krynytska, H., & Zhyliuk, V. (2026). Metabolic and structural hepatic changes in diabetes and intracerebral haemorrhage: Comparative study of lipid-lowering and antidiabetic drugs. Regulatory Mechanisms in Biosystems, 17(5), e26095. https://doi.org/10.15421/0226095
Vancouver
Dyomshyna O, Krynytska H, Zhyliuk V. Metabolic and structural hepatic changes in diabetes and intracerebral haemorrhage: Comparative study of lipid-lowering and antidiabetic drugs. Regulatory Mechanisms in Biosystems. 2026;17(5):e26095. doi:10.15421/0226095
BibTeX
@article{Dyomshyna2026,
author = {Dyomshyna, O. and Krynytska, H. and Zhyliuk, V.},
title = {Metabolic and structural hepatic changes in diabetes and intracerebral haemorrhage: Comparative study of lipid-lowering and antidiabetic drugs},
journal = {Regulatory Mechanisms in Biosystems},
year = {2026},
volume = {17},
number = {5},
pages = {e26095},
doi = {10.15421/0226095}
}
EUVIMED